A pharmaceutical/biotech company will be hosting a small patient and care-partner Medical Advisory Board meeting on Nov. 8-9 in Los Angeles.
 
The goal of this meeting it is to convene patients with a diagnosis of primary progressive multiple sclerosis and their care-partners to share their perceptions of PPMS care and treatment options, their own treatment choices, and their experiences and challenges with PPMS. This advice will inform and provide personal insight to the pharmaceutical/biotech company’s work in providing information about their product and appropriately engaging with the MS community in the future.
 
The pharmaceutical/biotech company will reimburse the travel expenses of invited participants, and provide an honorarium as thanks for their time and participation.
 
Participants must:

• Be between the ages of 18 and 55;
• Have a diagnosis (made by a physician) of PPMS for 3 to 10 years;
• Not currently be participating in an MS drug clinical trial;
• Have not previously participated in patient/care-partner Medical Advisory Board(s);
• Be interested in participating, with or without a care-partner; and
• Be willing and able to travel to Los Angeles, for a two half-day meeting on Nov. 8 and 9 in Los Angeles. The meeting will be held at a hotel within the LAX International Airport.

 
If you are interested in attending, email Ali Anastasia of Ashfield Healthcare at ali.anastasia@ashfieldhealthcare.com or call 203-918-9501.